AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Investing Activities | ₹-4,256 Cr | ₹-3,978 Cr | ₹-3,212 Cr | ₹599 Cr | ₹-1,568 Cr |
What is the latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA ?
Year | Cash Flow from Investing Activities |
---|---|
Mar2024 | ₹-4,256 Cr |
Mar2023 | ₹-3,978 Cr |
Mar2022 | ₹-3,212 Cr |
Mar2021 | ₹599 Cr |
Mar2020 | ₹-1,568 Cr |
How is Cash Flow from Investing Activities of AUROBINDO PHARMA Trending?
Years | Cash Flow from Investing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-4,256 Cr | Negative | |
Mar2023 | ₹-3,978 Cr | Negative | |
Mar2022 | ₹-3,212 Cr | Negative | |
Mar2021 | ₹599 Cr | Positive | |
Mar2020 | ₹-1,568 Cr | - |
Compare Cash Flow from Investing Activities of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹72,411.2 Cr | 4.9% | 3.1% | 11.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,894.0 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 4.9% |
3.1% |
11.4% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses